Novartis to acquire Avidity Biosciences for USD 12 billion
Novartis to Acquire Avidity Biosciences for $12 Billion Novartis has announced an agreement to acquire Avidity Biosciences, a biopharmaceutical company focused on RNA delivery to muscle.
GCash: No evidence of data breach
GCash: No Evidence of Data Breach E-wallet firm GCash reassured clients that their funds are secure following reports of an alleged data l…
No room for indiscipline - Minister warns - Ghana Business News
Minister Warns Against Indiscipline in Schools Mr Haruna Iddrisu, Minister of Education, has warned that the education sector will not tol…
Absa to acquire Standard Chartered’s retail business in Uganda
Absa to Acquire Standard Chartered's Retail Business in Uganda Africa Business Communities reports that Standard Chartered Bank Uganda and…
Pakistan’s ‘Iron Lady’ leads the fight a fairer future for all
Pakistan’s ‘Iron Lady’ Leads the Fight for a Fairer Future Muniba Mazari, known as the "Iron Lady of Pakistan," is a powerful voice as an …
Healthcare employee satisfactio falls for second straight month
Healthcare Employee Satisfaction Falls for Second Straight Month Employee satisfaction in healthcare and social sciences decreased by four…
Kinsta’s first CMO on his mission to make the brand a ‘verb’
Kinsta's New CMO: Making the Brand a Verb Matt Reid, Kinsta's first CMO, aims to elevate the brand's marketing efforts to drive its next p…
Australia Accuses Microsoft of Misleading Consumers With AI-Driven 365 Price Hikes
Australia Accuses Microsoft of Misleading Consumers Australia's ACCC has sued Microsoft for allegedly misleading 2.7 million users over AI…
Thamma Box Office Day 6: Ayushmann Khurrana-Rashmika Mandanna's film continues to spin magic, collects Rs 91.7 crore - Entertainment News | The Financial Express
Thamma Box Office Day 6: Ayushmann Khurrana-Rashmika Mandanna's Film Continues to Spin Magic The Diwali release, which hit theaters on Oct…
GCash finds no evidence of data breach, assures users - BusinessWorld Online
GCash Investigation Finds No Evidence of Data Breach GCash has released an official statement assuring users that their e-wallet funds and…
Health Canada Grants Authorization for "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease
Health Canada Approves LEQEMBI for Early Alzheimer's Treatment Eisai Co., Ltd. and Biogen Inc. announced that Health Canada has granted au…